WHO ARE WE?

SPGL is a dynamic and well established professional technical services group, operating in a range of market sectors including Bio-Pharmaceuticals, Medical Devices & Diagnostics, Healthcare, Regulated Consumer Products, Chemicals & Mission Critical.

A responsible, diverse and inclusive organisation, driven by its vision of ‘making quality a way of life’ and a strong desire to achieve more for its customers.

A group of highly skilled, smart professionals, helping, caring and supporting our clients and each other.

WHAT MAKES US DIFFERENT?

Our people are the backbone of our success, highly trained, experienced and educated scientists, engineers and consultants. Supported by the most advanced, practical and novel methodologies as well as our extensive electronic reference library, our team is able to offer an impressive and unparalleled service. 

Honed in the highly demanding world of regulated industries, our good practice know-how combined with our risk-based approach to quality and project execution is ideal for Life Science & Technology facilities, improving coordination between design, construction and occupancy. At SPGL, the final destination is important, however, the journey is paramount!

WHY SPGL?

In a fast-moving world, SPGL is helping Life Science & Technology companies integrate quality into all aspects of their projects, accelerate schedule and reduce ‘Time to Market’.

You need a strong, reliable and trusted partner who is able to get it right first time. You need a fast response and the assurance that you can get products to market in the shortest time possible. 

SPGL knows the challenges and offers quality solutions. Take a look at our experience, it speaks for itself.

Our Story

SPGL has great heritage! Established by Skanska, a Swedish construction giant known for building iconic structures such as London’s Swiss Re Tower, famously known as the ‘Gherkin’.

Formerly trading as Skanska Pharmaceutical Group, it was originally set-up in 2003 as an extension of Skanska’s USA Science & Technology division. Its primary purpose was to provide Quality & Regulatory ‘Know-How’ and help Skanska build, commission, qualify and validate Life Science facilities. The group was head-quartered in Philadelphia, USA, with offices in Puerto Rico and Europe.

In 2008, Skanska Pharmaceutical Group’s European division demerged from Skanska through a successful Management Buy-Out. The MBO was spearheaded by the current Managing Director Jay Lad and his team, who on completion of the buyout took over the running of three European offices: London, Dublin and Brussels.

Almost two decades on, the original management team is still together, driven by its ethos of hard work, fair play, teamwork and entrepreneurship. A nimble and adaptable organisation, with an enviable reputation for quality, excellence and exceptional service.


MENU